Who Should Pay Special Attention to Medication Storage Patients with inconsistent storage habits, frequent travel, or limited refrigerator access face higher risk of accidental medication degradation
In inflammatory bowel disease models including ulcerative colitis and cysteamine-induced colitis, BPC-157 reduces inflammatory markers (IL-6, TNF-, IL-1), improves mucosal architecture, and accelerates healing of damaged intestinal tissue
Dementia is the loss of cognitive function to the point that it affects your daily life: its symptoms include memory loss, confusion, impulsiveness, and getting lost in familiar places
SS-31 (Elamipretide): The First FDA-Approved Mitochondrial Therapeutic In September 2025, the FDA granted accelerated approval to Forzinity (elamipretide), marking a watershed moment in mitochondrial medicine
Phase Maintenance Weeks 25+ Tirzepatide 15.0 mg/week Cagrilintide 2.4 mg/week Notes Full 3-receptor coverage if tolerated
We are committed to providing personalized care and innovative treatments to support and guide you on your wellness journey